---
title: "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025"
ocid: "ocds-h6vhtk-04f707"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04f707"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-04f707.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-04f707.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "NHS ENGLAND"
published: "2025-03-21"
---

# NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025

Buyer: NHS ENGLAND  
Current stage: Planning  
OCID: ocds-h6vhtk-04f707

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04f707)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-04f707.json)

## Summary

NHS England, a central government public authority based in London, is planning to re-tender its National Framework for Medical Retinal Vascular Treatments. The procurement includes Anti VEG-F and Intravitreal Corticosteroid medicines, covering various conditions such as neovascular age-related macular degeneration, diabetic macular oedema, and non-infectious uveitis. The framework agreement is set to begin on 1 December 2025 and may be renewed up to 31 May 2029. Interested suppliers are invited to participate in virtual 1:1 preliminary market engagement meetings by 11 April 2025 to discuss tender structure and other aspects.

This tender presents an excellent opportunity for pharmaceutical companies specialising in medicinal products, particularly those focusing on ophthalmic treatments, to expand their business within the NHS framework. The procurement is well-suited for small and medium-sized enterprises (SMEs) looking to provide innovative solutions in medical retinal care. With a significant contract value exceeding £1.5 billion, this tender offers substantial growth potential for qualified suppliers capable of delivering high-quality therapeutic products. Interested businesses should prepare to engage in the detailed planning stage to align their offerings with NHS England's requirements and timelines.

## Notice

Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; * neovascular (wet) age-related macular degeneration (AMD) * visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) * proliferative diabetic retinopathy (PDR) * visual impairment due to diabetic macular oedema (DME) * visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy * vision impairment associated with chronic diabetic macular oedema, (DME) * visual impairment due to myopic choroidal neovascularisation (myopic CNV) * retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease * inflammation of the posterior segment of the eye presenting as non-infectious uveitis * prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye

### Planning Information

NHS England is pleased to invite suppliers to a virtual 1:1 preliminary market engagement meeting in relation to the upcoming re-tender of the Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines Framework. The purpose of the sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, clinical aspects and KPI's. Please contact b.kullootee@nhs.net or michelle.clarke6@nhs.net to register your interest. There will also be a 7 day window for queries to be raised in writing after all sessions have concluded.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/010543-2025 |
| Notice type | UK2 - Preliminary Market Engagement Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | SME |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 21 Mar 2025 |
| Submission deadline | Not specified |
| Future notice date | 2 Jun 2025 |
| Award date | Not specified |
| Contract period | 1 Dec 2025 - 31 May 2027 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £1,516,353,164 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planning |
| Lots status | Planning |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LONDON |
| Post town | South East London |
| Postcode | SE1 8UG |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI45 Lambeth |
| Local authority | Lambeth |
| Electoral ward | Waterloo & South Bank |
| Westminster constituency | Vauxhall and Camberwell Green |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products
- 33690000 - Various medicinal products

## Release History

- 21 Mar 2025 at 08:17 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/010543-2025

## Documents

- https://www.find-tender.service.gov.uk/Notice/010543-2025
  21st March 2025 - Preliminary market engagement notice on Find a Tender

## Notice URLs

- https://www.england.nhs.uk/
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04f707. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-04f707.json.